AgomAb Therapeutics NV (AGMB)
12.14
+0.06
(+0.50%)
USD |
NASDAQ |
Sep 18, 16:00
12.14
0.00 (0.00%)
After-Hours: 18:40
AgomAb Therapeutics Total Liabilities (Quarterly) : 26.78M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 26.78M |
| Date | Value |
|---|---|
| December 31, 2024 | 18.93M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | 112.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 180.52M |
| Shareholders Equity (Quarterly) | 153.74M |
| Debt to Equity Ratio | 0.0096 |
| Current Ratio | 6.488 |